Efficacy and safety of serial injections of botulinum toxin A in children with spastic cerebral palsy

[1] Hagberg B(1996)The changing panorama of cerebral palsy-bilateral spastic forms in particular Acta Paediatr Suppl 416 48-52

[2] Hagberg G(2006)Cerebral palsy: an overview Am Fam Physician 73 91-100

[3] Krigger KW(1996)Neuromuscular blockade in the management of cerebral palsy J Child Neurol 1 S23-28

[4] Koman LA(1971)Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin J Neurol Sci 14 61-74

[5] Mooney JF(1976)Botulinum toxin: mechanism of presynaptic blockade Science 193 1256-1258

[6] Smith BP(2000)Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A Infect Immun 68 2587-2593

[7] Duchen LW(1993)Botulinum toxin From poison to medicine. West J Med 158 25-29

[8] Kao I(2000)Pharmacology of botulinum toxin J Am Acad Dermatol 43 249-259

[9] Drachman DB(1999)Functional repair of motor endplates after botulinumo nertotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals Proc Natl Acad Sci U S A 96 3200-3205

[10] Price DL(2009)Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy Arq Neuropsiquiatr 67 62-68

[1] Hagberg B(1996)The changing panorama of cerebral palsy-bilateral spastic forms in particular Acta Paediatr Suppl 416 48-52

[2] Hagberg G(2006)Cerebral palsy: an overview Am Fam Physician 73 91-100

[3] Krigger KW(1996)Neuromuscular blockade in the management of cerebral palsy J Child Neurol 1 S23-28

[4] Koman LA(1971)Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin J Neurol Sci 14 61-74

[5] Mooney JF(1976)Botulinum toxin: mechanism of presynaptic blockade Science 193 1256-1258

[6] Smith BP(2000)Inhibition of vesicular secretion in both neuronal and nonneuronal cells by a retargeted endopeptidase derivative of Clostridium botulinum neurotoxin type A Infect Immun 68 2587-2593

[7] Duchen LW(1993)Botulinum toxin From poison to medicine. West J Med 158 25-29

[8] Kao I(2000)Pharmacology of botulinum toxin J Am Acad Dermatol 43 249-259

[9] Drachman DB(1999)Functional repair of motor endplates after botulinumo nertotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals Proc Natl Acad Sci U S A 96 3200-3205

[10] Price DL(2009)Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy Arq Neuropsiquiatr 67 62-68